Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective

Heidi Schulz1, Susan Bigelow, Roxanne Dobish

  • 1Cross Cancer Institute Site, Edmonton, Alberta, Canada. heidis@cancerboard.ab.ca

Summary

Routine monitoring for workplace antineoplastic agent contamination is feasible in pharmacy settings. While most surfaces showed no contamination, exterior vials require attention, indicating a need for ongoing vigilance in cancer drug handling.